Crossmark

A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines

Crossref DOI link: https://doi.org/10.1007/s12094-018-02025-3

Published Online: 2019-01-10

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, L.

Gülses, A. https://orcid.org/0000-0001-5760-8103
Purcz, N.

Weimer, J.

Wiltfang, J.

Açil, Y.
License Information

Text and Data Mining valid from 2019-01-10
More Information

Article History

Received: 3 October 2018

Accepted: 20 December 2018

First Online: 10 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The experiments carried out were approved by the Ethics Committee of the Christian-Albrechts-University Kiel, Germany (AZ.D417/09).

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below